These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
312 related articles for article (PubMed ID: 35457198)
1. Metastatic Voyage of Ovarian Cancer Cells in Ascites with the Assistance of Various Cellular Components. Uno K; Iyoshi S; Yoshihara M; Kitami K; Mogi K; Fujimoto H; Sugiyama M; Koya Y; Yamakita Y; Nawa A; Kanayama T; Tomita H; Enomoto A; Kajiyama H Int J Mol Sci; 2022 Apr; 23(8):. PubMed ID: 35457198 [TBL] [Abstract][Full Text] [Related]
2. Mesothelial cells interact with tumor cells for the formation of ovarian cancer multicellular spheroids in peritoneal effusions. Matte I; Legault CM; Garde-Granger P; Laplante C; Bessette P; Rancourt C; Piché A Clin Exp Metastasis; 2016 Dec; 33(8):839-852. PubMed ID: 27612856 [TBL] [Abstract][Full Text] [Related]
3. TGFβ signaling regulates epithelial-mesenchymal plasticity in ovarian cancer ascites-derived spheroids. Rafehi S; Ramos Valdes Y; Bertrand M; McGee J; Préfontaine M; Sugimoto A; DiMattia GE; Shepherd TG Endocr Relat Cancer; 2016 Mar; 23(3):147-59. PubMed ID: 26647384 [TBL] [Abstract][Full Text] [Related]
4. BMP signalling controls the malignant potential of ascites-derived human epithelial ovarian cancer spheroids via AKT kinase activation. Peart TM; Correa RJ; Valdes YR; Dimattia GE; Shepherd TG Clin Exp Metastasis; 2012 Apr; 29(4):293-313. PubMed ID: 22249415 [TBL] [Abstract][Full Text] [Related]
5. Modulation of AKT activity is associated with reversible dormancy in ascites-derived epithelial ovarian cancer spheroids. Correa RJ; Peart T; Valdes YR; DiMattia GE; Shepherd TG Carcinogenesis; 2012 Jan; 33(1):49-58. PubMed ID: 22045027 [TBL] [Abstract][Full Text] [Related]
6. Re-purposing of curcumin as an anti-metastatic agent for the treatment of epithelial ovarian cancer: in vitro model using cancer stem cell enriched ovarian cancer spheroids. He M; Wang D; Zou D; Wang C; Lopes-Bastos B; Jiang WG; Chester J; Zhou Q; Cai J Oncotarget; 2016 Dec; 7(52):86374-86387. PubMed ID: 27863439 [TBL] [Abstract][Full Text] [Related]
7. SMIFH2-mediated mDia formin functional inhibition potentiates chemotherapeutic targeting of human ovarian cancer spheroids. Ziske MA; Pettee KM; Khaing M; Rubinic K; Eisenmann KM Biochem Biophys Res Commun; 2016 Mar; 472(1):33-9. PubMed ID: 26898799 [TBL] [Abstract][Full Text] [Related]
8. Myxoma virus-mediated oncolysis of ascites-derived human ovarian cancer cells and spheroids is impacted by differential AKT activity. Correa RJ; Komar M; Tong JG; Sivapragasam M; Rahman MM; McFadden G; Dimattia GE; Shepherd TG Gynecol Oncol; 2012 May; 125(2):441-50. PubMed ID: 22306204 [TBL] [Abstract][Full Text] [Related]
9. Intact LKB1 activity is required for survival of dormant ovarian cancer spheroids. Peart T; Ramos Valdes Y; Correa RJ; Fazio E; Bertrand M; McGee J; Préfontaine M; Sugimoto A; DiMattia GE; Shepherd TG Oncotarget; 2015 Sep; 6(26):22424-38. PubMed ID: 26068970 [TBL] [Abstract][Full Text] [Related]
10. SMYD3 promotes implant metastasis of ovarian cancer via H3K4 trimethylation of integrin promoters. Lyu T; Jiang Y; Jia N; Che X; Li Q; Yu Y; Hua K; Bast RC; Feng W Int J Cancer; 2020 Mar; 146(6):1553-1567. PubMed ID: 31503345 [TBL] [Abstract][Full Text] [Related]
12. Ascites microenvironment conditions the peritoneal pre-metastatic niche to promote the implantation of ovarian tumor spheroids: Involvement of fibrinogen/fibrin and αV and α5β1 integrins. Laurent-Issartel C; Landras A; Agniel R; Giffard F; Blanc-Fournier C; Da Silva Cruz E; Habes C; Leroy-Dudal J; Carreiras F; Kellouche S Exp Cell Res; 2024 Aug; 441(1):114155. PubMed ID: 39002689 [TBL] [Abstract][Full Text] [Related]
13. Molecular and cellular mechanisms controlling integrin-mediated cell adhesion and tumor progression in ovarian cancer metastasis: a review. Dhaliwal D; Shepherd TG Clin Exp Metastasis; 2022 Apr; 39(2):291-301. PubMed ID: 34822024 [TBL] [Abstract][Full Text] [Related]
14. Multicellular detachment generates metastatic spheroids during intra-abdominal dissemination in epithelial ovarian cancer. Al Habyan S; Kalos C; Szymborski J; McCaffrey L Oncogene; 2018 Sep; 37(37):5127-5135. PubMed ID: 29789717 [TBL] [Abstract][Full Text] [Related]
15. Single-Cell Sequencing of Malignant Ascites Reveals Transcriptomic Remodeling of the Tumor Microenvironment during the Progression of Epithelial Ovarian Cancer. Li Y; Wang W; Wang D; Zhang L; Wang X; He J; Cao L; Li K; Xie H Genes (Basel); 2022 Dec; 13(12):. PubMed ID: 36553542 [TBL] [Abstract][Full Text] [Related]
16. AMPK-Independent LKB1 Activity Is Required for Efficient Epithelial Ovarian Cancer Metastasis. Buensuceso A; Ramos-Valdes Y; DiMattia GE; Shepherd TG Mol Cancer Res; 2020 Mar; 18(3):488-500. PubMed ID: 31744879 [TBL] [Abstract][Full Text] [Related]
17. The Transcoelomic Ecosystem and Epithelial Ovarian Cancer Dissemination. Ritch SJ; Telleria CM Front Endocrinol (Lausanne); 2022; 13():886533. PubMed ID: 35574025 [TBL] [Abstract][Full Text] [Related]
18. An mDia2/ROCK signaling axis regulates invasive egress from epithelial ovarian cancer spheroids. Pettee KM; Dvorak KM; Nestor-Kalinoski AL; Eisenmann KM PLoS One; 2014; 9(2):e90371. PubMed ID: 24587343 [TBL] [Abstract][Full Text] [Related]
19. Metabolic adaptation in epithelial ovarian cancer metastasis. Frederick MI; Nassef MZ; Borrelli MJ; Kuang S; Buensuceso A; More T; Cordes T; O'Donoghue P; Shepherd TG; Hiller K; Heinemann IU Biochim Biophys Acta Mol Basis Dis; 2024 Oct; 1870(7):167312. PubMed ID: 38901649 [TBL] [Abstract][Full Text] [Related]